Sanctuary Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Sanctuary Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.54M	Buy	74,865 +1,341	+2%	+$44.7K	0.01%	921
2026 Q1	$2.21M	Buy	73,524 +1,423	+2%	+$45.8K	0.01%	915
2025 Q4	$2.25M	Buy	72,101 +104	+0.1%	+$2.56K	0.01%	866
2025 Q3	$1.45M	Buy	71,997 +766	+1%	+$13.5K	0.01%	1069
2025 Q2	$1.19M	Sell	71,231 -8,831	-11%	-$143K	0.01%	1120
2025 Q1	$1.23M	Sell	80,062 -1,581	-2%	-$28.2K	0.01%	1031
2024 Q4	$1.46M	Buy	81,643 +46,514	+132%	+$846K	0.01%	1040
2024 Q3	$601K	Buy	35,129 +664	+2%	+$11.6K	﹤0.01%	1585
2024 Q2	$476K	Buy	+34,465	New	+$531K	﹤0.01%	1674

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Sanctuary Advisors's TEVA Position: Q2 2026 in Review

Sanctuary Advisors increased its Teva Pharmaceutical Industries Limited (TEVA) stake by 1.8% in Q2 2026, buying an estimated $44.7K and bringing the position to 74,865 shares worth $2.54M. The position accounts for 0.01% of the portfolio, ranked #921.

Sanctuary Advisors first reported a position in TEVA in Q2 2024 and has held it in 9 quarters since. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Sanctuary Advisors held 74,865 shares of Teva Pharmaceutical Industries Limited worth $2.54M as of Q2 2026.
Sanctuary Advisors bought 1,341 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $44.7K.
Teva Pharmaceutical Industries Limited made up 0.01% of Sanctuary Advisors's portfolio in Q2 2026, its #921 holding.
Sanctuary Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q2 2024 and has held it in 9 quarters since.
676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.